NASDAQ:SCPH
Delisted

Scpharmaceuticals Stock Insider Trading

etoro logo Buy SCPH
*Your capital is at risk
$5.67
+0 (+0%)
At Close: Jan 06, 2026

scPharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -95.05. In total, the insiders bought 480K and sold 5.06M SCPH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-95.05
Buy 480K shares
Sell 5.06M shares
16% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Oct 07, 2025

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -95.05.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming sell-side pressure (16% buys).

Historical Insider Trades

Date Type Person Role Amount
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Abraham William Tober
Director
Director 30 000
Value: $115.5K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Veitinger Klaus R Dr
Director
Director 6 124
Value: $20.6K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Veitinger Klaus R Dr
Director
Director 16 300
Value: $73.8K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Veitinger Klaus R Dr
Director
Director 19 750
Value: $81.2K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Veitinger Klaus R Dr
Director
Director 30 000
Value: $115.5K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Schaeffer Leonard D
Director
Director 16 300
Value: $73.8K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Schaeffer Leonard D
Director
Director 19 750
Value: $81.2K
Oct 07, 2025
Sell
Stock Option (Right to Buy)
D-Return
Schaeffer Leonard D
Director
Director 30 000
Value: $115.5K
Oct 07, 2025
Sell
Common Stock
U-Tender
Schaeffer Leonard D
Director
Director 43 104
Value: $0
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Agger Mette Kirstine
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Baylor-henry Minnie
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bonstein Sara
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hudson Frederick M.
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Khattar Jack A.
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Veitinger Klaus R Dr
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Abraham William Tober
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Schaeffer Leonard D
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Schaeffer Leonard D
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Abraham William Tober
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Veitinger Klaus R Dr
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Khattar Jack A.
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hudson Frederick M.
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Agger Mette Kirstine
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bonstein Sara
Director
Director 30 000
Value: $115.5K
Jun 03, 2025
Buy
Stock Option (Right to Buy)
A-Award
Baylor-henry Minnie
Director
Director 30 000
Value: $115.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SCPHARMACEUTICALS INC.
scPharmaceuticals
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE